Concepedia

Subasree Srinivasan

SS

Statistics

Publications

4

Citations

150

H-Index

4

Active since

1998

Affiliations

Pfizer (United States)(Current)

Quest Clinical Research (United States)

Seno Medical (United States)

University of Oklahoma

Scripps Clinic

Subasree Srinivasan is an author at Pfizer (United States) specializing in infectious diseases, antiviral therapy, and viral hepatitis.

Publications per year

1998–2011

4

Publications

4

The Innate Immune Response, Clinical Outcomes, and Ex Vivo HCV Antiviral Efficacy of a TLR7 Agonist (PF-4878691)

Mark Fidock, B E Souberbielle, Carl Laxton et al. · Clinical Pharmacology & Therapeutics · 2011 · 70 citations

, , +17

1052 ANTIVIRAL ACTIVITY OF FILIBUVIR IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN FOR 28 DAYS IN TREATMENT NAIVE PATIENTS CHRONICALLY INFECTED WITH HCV GENOTYPE 1

Ira M. Jacobson, Paul J. Pockros, Jacob Lalezari et al. · Journal of Hepatology · 2009 · 42 citations

, , +10

2005 VIROLOGIC RESPONSE RATES FOLLOWING 4 WEEKS OF FILIBUVIR IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN CHRONICALLY-INFECTED HCV GENOTYPE-1 PATIENTS

Ira M. Jacobson, Paul J. Pockros, Jacob Lalezari et al. · Journal of Hepatology · 2010 · 22 citations · Full text

, , +12

Antibodies to Cag A protein are not predictive of serious gastroduodenal disease in Indian patients.

Suresh Kumar, Anjan Dhar, Subasree Srinivasan et al. · PubMed · 1998 · 16 citations

, , +8

1–4 of 4